20 results
8-K
EX-10.4
NTBL
Notable Labs Ltd
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
applicable standards of professional conduct due to a conflict of interest between Indemnitee and the Company, in either of which events set forth in clauses
424B3
NTBL
Notable Labs Ltd
5 Sep 23
Prospectus supplement
6:02pm
. These scientists and consultants are not VBL’s employees and may have other commitments that would limit their future availability to VBL. If a conflict … of interest arises between their work for VBL and their work for another entity, VBL may lose their services. In addition, VBL is limited in its
S-4/A
bjs0qib
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
4h9i mdzxf
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-1.1
quisx 90yiglg6fsms
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
20-F
0wg3 m89yjf7k6eewd2
25 Mar 15
Annual report (foreign)
12:00am
6-K
vp44la3j
6 Jan 15
Current report (foreign)
12:00am
424B4
c8fdl5shc0sdz1eml
2 Oct 14
Prospectus supplement with pricing info
12:00am
424B4
sjelyci0
1 Aug 14
Prospectus supplement with pricing info
12:00am
- Prev
- 1
- Next